BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8276019)

  • 1. X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinaemia from common variable immunodeficiency.
    Tsuge I; Matsuoka H; Abe T; Kamachi Y; Torii S
    Eur J Pediatr; 1993 Nov; 152(11):900-4. PubMed ID: 8276019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier detection in agammaglobulinemia by X chromosome inactivation analysis.
    Miyashita T; Iwata T; Mizutani S; Kamoshita S; Kobayashi N
    Acta Paediatr Jpn; 1992 Jun; 34(3):267-72. PubMed ID: 1354911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency.
    Goodship J; Malcolm S; Lau YL; Pembrey ME; Levinsky RJ
    Lancet; 1988 Apr; 1(8588):729-32. PubMed ID: 2895261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cells.
    Alterman LA; de Alwis M; Genet S; Lovering R; Middleton-Price H; Morgan G; Jones A; Malcolm S; Levinsky RJ; Kinnon C
    J Immunol Methods; 1993 Nov; 166(1):111-6. PubMed ID: 8228281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females.
    Gale RE; Wheadon H; Linch DC
    Br J Haematol; 1991 Oct; 79(2):193-7. PubMed ID: 1958476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal haematopoiesis in children with acquired aplastic anaemia.
    Tsuge I; Kojima S; Matsuoka H; Abe T; Kamachi Y; Torii S; Matsuyama T
    Br J Haematol; 1993 May; 84(1):137-43. PubMed ID: 8338766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry.
    Kanegane H; Tsukada S; Iwata T; Futatani T; Nomura K; Yamamoto J; Yoshida T; Agematsu K; Komiyama A; Miyawaki T
    Clin Exp Immunol; 2000 Jun; 120(3):512-7. PubMed ID: 10844531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier detection and prenatal diagnosis of X-linked agammaglobulinemia.
    Journet O; Durandy A; Doussau M; Le Deist F; Couvreur J; Griscelli C; Fischer A; de Saint-Basile G
    Am J Med Genet; 1992 Jul; 43(5):885-7. PubMed ID: 1642281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal CD45R expression in patients with common variable immunodeficiency and X-linked agammaglobulinaemia.
    Richards SJ; Scott CS; Cole JC; Gooi HC
    Br J Haematol; 1992 Jun; 81(2):160-6. PubMed ID: 1386525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
    Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
    Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X linked agammaglobulinaemia with a 'leaky' phenotype.
    Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G
    Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier identification in X-linked immunodeficiency diseases.
    Li SL; Ting SS; Lindeman R; Ffrench R; Ziegler JB
    J Paediatr Child Health; 1998 Jun; 34(3):273-9. PubMed ID: 9633977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PCR based X-chromosome inactivation assay for carrier detection in X-linked immunodeficiencies using differential methylation of the androgen receptor gene.
    Schmucker B; Meindl A; Achatz H; Mittermüller J; Krüger G; Hergersberg M; Spiegel R; Schinzel A; Belohradsky BH; Murken J
    Immunodeficiency; 1995; 5(3):187-92. PubMed ID: 7749438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier detection in the Wiskott Aldrich syndrome.
    Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
    Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of two X chromosome genes in female somatic and embryonal carcinoma cells.
    Bartlett MH; Adra CN; Park J; Chapman VM; McBurney MW
    Somat Cell Mol Genet; 1991 Jan; 17(1):35-47. PubMed ID: 1998141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier detection in typical and atypical X-linked agammaglobulinemia.
    Conley ME; Puck JM
    J Pediatr; 1988 May; 112(5):688-94. PubMed ID: 2896233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.
    Fearon ER; Winkelstein JA; Civin CI; Pardoll DM; Vogelstein B
    N Engl J Med; 1987 Feb; 316(8):427-31. PubMed ID: 2880293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential patterns of histone methylation and acetylation distinguish active and repressed alleles at X-linked genes.
    Goto Y; Gomez M; Brockdorff N; Feil R
    Cytogenet Genome Res; 2002; 99(1-4):66-74. PubMed ID: 12900547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact.
    Hendriks RW; Kraakman ME; Craig IW; Espanol T; Schuurman RK
    Eur J Immunol; 1990 Dec; 20(12):2603-8. PubMed ID: 1980111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.